ChatGPT has taken the world by storm; every industry is experimenting with the AI technology, and pharma is no exception. This episode's guest, Bill Pittenger, may be the biggest evangelist for AI in pharmaceutical market access. Bill is SVP, Director of Digital Growth & Operations for Entrée Health.
ChatGPT, the artificial intelligence tool that generates text and allows you to have human-like conversations, was released in November of last year.
Today, you can ask ChatGPT to write a business plan to commercialize market access for your new prescription drug -- and it will do so in seconds.
Bill Pittenger, SVP, Director of Digital Growth & Operations for Entrée Health, is experimenting with ChatGPT and other AI tools for market access. Bill explains how and why ChatGPT and other AI tools will transform market access for the better in today's episode.
Follow Bill Pittenger on LinkedIn.
Follow Valuate on LinkedIn or visit us at ValuateHealth.com.